Tuesday, June 21, 2016

BRIEF-Redhill Biopharma says Yeliva met main goal in early-stage study in solid tumors

* Redhill biopharma announces positive final results with

primary and secondary endpoints met in phase 1 study with

yeliva in advanced solid tumors

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)